Kazuo Komamura

Kazuo Komamura

Auto-generated profile, based on publicly available information

Kazuo Komamura

Toyota Memorial Hospital, Toyota, Aichi, Japan

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2014 in World Journal of Cardiology
Verified
Journal Article
Open access
KKKazuo Komamura
Kazuo Komamura
MFMiho Fukui
Miho Fukui
TIToshihiro Iwasaku
Toshihiro Iwasaku
SHShinichi Hirotani
Shinichi Hirotani
TMTohru Masuyama
Tohru Masuyama
In 1990, takotsubo cardiomyopathy (TCM) was first discovered and reported by a Japanese cardiovascular specialist. Since then, this heart disease has gained worldwide acceptance as an independent disease entity. TCM is an important entity that differs from acute myocardial infarction. It occurs more often in postmenopausal elderly women, is characterized by a transient hypokinesis of the left ventricular (LV) apex, and is associated with emotional or physical stress. Wall motion abnormality of the LV apex is generally transient and resolves within a few days to several weeks. Its prognosis is generally good. However, there are some reports of serious TCM complications, including hypotension, heart failure, ventricular rupture, thrombosis involving the LV apex, and torsade de pointes. It has been suggested that coronary spasm, coronary microvascular dysfunction, catecholamine toxicity and myocarditis might contribute to the pathogenesis of TCM. However, its pathophysiology is not clearly understood.

29 December 2013 in Cardiology Research and Practice
Verified
Journal Article
Open access
PDF file
KKKazuo Komamura
Kazuo Komamura
Pathophysiology of heart failure has been considered to be a damaged state of systolic function of the heart followed by a state of low cardiac output that is, systolic heart failure. Even if systolic function is preserved, left ventricular filling in diastole can be impeded and resulted in elevation of filling pressure and symptoms of heart failure. This kind of heart failure is called diastolic heart failure. Nowadays, diastolic heart failure is referred to as heart failure with preserved ejection fraction (HFpEF), whereas systolic heart failure is referred to as heart failure with reduced ejection fraction (HFrEF). In this paper, the similarities and differences between the pathogenesis and pathophysiology of diastolic and systolic heart failure were reviewed. Although diastolic heart failure is a common condition of heart failure worldwide, its pathophysiology has not been sufficiently elucidated. This is thought to be the most significant reason for a lack of established treatment methods for diastolic heart failure. We hope to proceed with future studies on this topic.

1 September 1996 in Journal of Molecular and Cellular Cardiology
Verified
Journal Article
Closed access
PDF file
MKMasafumi Kitakaze
Masafumi Kitakaze
TMTetsuo Minamino
Tetsuo Minamino
KNKoichi Node
Koichi Node
KKKazuo Komamura
Kazuo Komamura
MIMichitoshi Inoue
Michitoshi Inoue
TKTakenobu Kamada
Takenobu Kamada

1 December 1995 in Arteriosclerosis, Thrombosis, and Vascular Biology
Verified
Journal Article
Open access
TMTetsuo Minamino
Tetsuo Minamino
MKMasafumi Kitakaze
Masafumi Kitakaze
KKKazuo Komamura
Kazuo Komamura
KNKoichi Node
Koichi Node
HTHiroshi Takeda
Hiroshi Takeda
TKTakenobu Kamada
Takenobu Kamada
Both ischemia and hypoxia increase adenosine production in the heart. This study tested whether hypoxia increases adenosine production in the coronary artery via ecto-5′-nucleotidase and the role of protein kinase C in this condition. Canine left circumflex coronary artery was rapidly removed and incubated in 10 mL Krebs-Henseleit solution for 30 minutes. The Krebs-Henseleit solution contained 5′-iodotubercidin and 2′-deoxycoformycin, which inhibit adenosine kinase and adenosine deaminase, respectively. Adenosine production was measured in intact coronary arteries under normoxic conditions (16.2±1.2 pmol/mg protein). Adenosine production was reduced by 27% after removal of endothelium. Ecto-5′-nucleotidase activity of coronary arteries with and without endothelium was 51±6 and 41±4 nmol/mg protein per minute under normoxic conditions. Hypoxia increased adenosine production to 27.0±2.3 and 20.0±0.8 pmol/mg protein with and without endothelium. Hypoxia also increased ecto-5′-nucleotidase activity of coronary arteries with and without endothelium (74±8 and 53±5 nmol/mg protein per minute;P<.05). Increases in adenosine production under hypoxic conditions were blunted by both an inhibitor of ecto-5′-nucleotidase and inhibitors of protein kinase C. Activation of ecto-5′-nucleotidase was blunted by an inhibitor of protein kinase C. These results indicate that hypoxia increased extracellular adenosine production and activated ecto-5′-nucleotidase via activation of protein kinase C in coronary arterial smooth muscle and endothelial cells. Increased adenosine production in coronary arteries during hypoxia may contribute to coronary vasodilation and cardioprotection against ischemic injury.

1 January 2010 in Internal Medicine
Verified
Journal Article
Open access
PDF file
NONoboru Oda
Noboru Oda
TKTomoko S. Kato
Tomoko S. Kato
AHAkihisa Hanatani
Akihisa Hanatani
KNKazuo Niwaya
Kazuo Niwaya
TNTakeshi Nakatani
Takeshi Nakatani
KKKazuo Komamura
Kazuo Komamura
Reversible posterior leukoencephalopathy syndrome (RPLS) is one of the important adverse events following organ transplantation, associated with calcineurin inhibitors (CNIs). We describe a case of 54-year-old woman, who was diagnosed with RPLS within weeks after transplantation. Considering the risk of causing fatal rejection by discontinuation of CNIs, the immunosuppressive regimen of the patient was switched from a cyclosporine A-based regimen to a tacrolimus-based regimen. The patient recovered rapidly from RPLS following the switch to tacrolimus. This case demonstrated that not only discontinuation but also a substitution of CNIs would be a valid treatment option for RPLS in transplant recipients.

1 December 1994 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
MKM Kitakaze
M Kitakaze
MHM Hori
M Hori
Tohru MinaminoTohru Minamino
Tohru Minamino
STS Takashima
S Takashima
KKK Komamura
K Komamura
MIM Inoue
M Inoue
Adenosine, an important regulator of many cardiac functions, is produced by ectosolic and cytosolic 5'-nucleotidase. The activity of these enzymes is influenced by several ischemia-sensitive metabolic factors, e.g., ATP, ADP, H+, and inorganic phosphate. However, there is no clear evidence that adenosine itself affects 5'-nucleotidase activity. This study tested whether adenosine decreases the activity of ectosolic and cytosolic 5'-nucleotidase. Cardiomyocytes were isolated from adult male Wistar rats and suspended in the modified Hepes-Tyrode buffer solution. After stabilization, isolated cardiomyocytes were incubated with and without adenosine (10(-9) - 10(-4) M). Ectosolic and cytosolic 5'-nucleotidase activity was decreased by exogenous adenosine (ectosolic 5'-nucleotidase activity, 20.6 +/- 2.3 vs. 8.6 +/- 1.6 mumol/min per 10(6) cells [P < 0.05]; cytosolic 5'-nucleotidase activity, 2.47 +/- 0.58 vs. 1.61 +/- 0.54 mumol/min per 10(6) cells [P < 0.05] at 10(-6) M adenosine) after 30 min. The decrease in ectosolic and cytosolic 5'-nucleotidase activity was inhibited by 8-phenyltheophylline and pertussis toxin, and was mimicked by N6-cyclohexyladenosine, an adenosine A1 receptor agonist. Neither CGS21680C, and A2 receptor agonist, nor cycloheximide deactivated ectosolic and cytosolic 5'-nucleotidase. Thus, we conclude that activation of adenosine A1 receptors is coupled to Gi proteins and attenuates ectosolic and cytosolic 5'-nucleotidase activity in rat cardiomyocytes.